Opens in a new tab or window Missed doses of prophylactic anticoagulation account for much of the deep vein thrombosis (DVT ... including the mean platelet count, fibrinogen level, partial ...

DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep ...

Recent CNS bleeding, intracranial or spinal lesion at high risk for bleeding, active major bleeding (>2 units transfused in 24 hr), chronic bleeding >48 hr, thrombocytopenia (platelet count of ...

To discuss the evidence regarding the efficacy and safety of anticoagulant prophylaxis against deep vein thrombosis (DVT) in hospitalized medical patients; to understand barriers to implementation of ...

Combating patient noncompliance with DVT prophylaxis Successful DVT prophylaxis with pharmacologic agents and adjunctive treatment modalities depends on both consistency and accuracy. Before ...

As a result of the Surgeon General's call to action in 2008 to prevent deep-vein thrombosis and pulmonary ... and Quality has stated that providing prophylaxis against venous thromboembolism ...

“The FDA approval of Eliquis gives U.S. orthopedic surgeons a new option for DVT prophylaxis in both hip and knee replacement surgery.” ...

Bristol-Myers Squibb and Pfizer announced that the FDA has accepted for review a supplemental New Drug Application (sNDA) for Eliquis (apixaban), for prophylaxis of deep vein thrombosis (DVT ...